drugset / Trial / NCT06607549
Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to learn if drugs loncastuximab tesirine and rituximab (lonca-R) after stereotactic radiosurgery are safe and effective for treatment of central nervous system lymphomas.
Timeline
- Start
- 2025-03-18
- Primary completion
- 2029-11
- Completion
- 2030-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loncastuximab Tesirine | Other / unclassified | — | Intravenous |
| Subject | Rituximab | Monoclonal antibody | — | Intravenous |